Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Laetitia Florenceau"'
Autor:
Catherine Rabu, Laurie Rangan, Laetitia Florenceau, Agnès Fortun, Maud Charpentier, Emilie Dupré, Léa Paolini, Céline Beauvillain, Estelle Dupel, Jean-Baptiste Latouche, Olivier Adotevi, Nathalie Labarrière, François Lang
Publikováno v:
OncoImmunology, Vol 8, Iss 4 (2019)
There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T cell responses. To this aim, in recent trials, pa
Externí odkaz:
https://doaj.org/article/f1026e16e4944382a2c78a43cfd2f7c5
Autor:
Mathilde Bobinet, Virginie Vignard, Laetitia Florenceau, Francois Lang, Nathalie Labarriere, Agnès Moreau-Aubry
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75421 (2013)
The melanoma antigens MELOE-1 and MELOE-2 are encoded by a messenger, called meloe, overexpressed in melanomas compared with other tumour cell types and healthy tissues. They are both able to elicit melanoma-specific T cell responses in melanoma pati
Externí odkaz:
https://doaj.org/article/c77bf5b22fde4f0db0263c27d22b9484
Autor:
Delphine Carbonnelle, Virginie Vignard, Delphine Sehedic, Agnes Moreau-Aubry, Laetitia Florenceau, Maud Charpentier, Wolfgang Mikulits, Nathalie Labarriere, François Lang
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75233 (2013)
Our previous studies on melanoma antigens identified two new polypeptides, named MELOE-1 and MELOE-2, that are involved in immunosurveillance. Intriguingly, these antigens are coded by distinct open reading frames (ORF) of the meloe mRNA which is sig
Externí odkaz:
https://doaj.org/article/1d1db63783204ef6b03048f3b617beab
Autor:
Nathalie Labarrière, Pauline Gaboriaud, Laetitia Florenceau, Virginie Vignard, Delphine Fradin, Astrid Blom, Mahtab Samimi, Thibault Kervarrec, Houssem Benlalam, Pascal Aumond, Nadine Gervois, Antoine Touzé
Publikováno v:
Cellular Immunology
Cellular Immunology, Elsevier, 2019, 344, pp.103961. ⟨10.1016/j.cellimm.2019.103961⟩
Cellular Immunology, 2019, 344, 8 p. ⟨10.1016/j.cellimm.2019.103961⟩
Cellular Immunology, Elsevier, 2019, 344, 8 p. ⟨10.1016/j.cellimm.2019.103961⟩
Cellular Immunology, Elsevier, 2019, 344, pp.103961. ⟨10.1016/j.cellimm.2019.103961⟩
Cellular Immunology, 2019, 344, 8 p. ⟨10.1016/j.cellimm.2019.103961⟩
Cellular Immunology, Elsevier, 2019, 344, 8 p. ⟨10.1016/j.cellimm.2019.103961⟩
International audience; Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous cancer, which is immunogenic, regardless of the presence of MCPyV (80% of cases). The identification of MCC-specific epitopes recognized by CD8 T cells is crucial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ed1bfb8227c1926138b3166bda344e
https://www.hal.inserm.fr/inserm-02284748/file/1-s2.0-S0008874919302266-main.pdf
https://www.hal.inserm.fr/inserm-02284748/file/1-s2.0-S0008874919302266-main.pdf
Autor:
Léa Paolini, Olivier Adotevi, Maud Charpentier, E Dupel, Agnès Fortun, Emilie Dupré, Catherine Rabu, Nathalie Labarrière, Céline Beauvillain, L. Rangan, Jean-Baptiste Latouche, François Lang, Laetitia Florenceau
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, 2019, 8 (4), pp.e1560919. ⟨10.1080/2162402X.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
Oncoimmunology
OncoImmunology, Vol 8, Iss 4 (2019)
OncoImmunology, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, 8 (4), pp.e1560919. ⟨10.1080/2162402X.2018.1560919⟩
OncoImmunology, Taylor & Francis, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
Oncoimmunology
OncoImmunology, Vol 8, Iss 4 (2019)
OncoImmunology, 2019, pp.e1560919-2. ⟨10.1080/2162402x.2018.1560919⟩
International audience; There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T cell responses. To this a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbd5c6d1e4eb958168d0931139ddca4f
https://hal.archives-ouvertes.fr/hal-02131764/document
https://hal.archives-ouvertes.fr/hal-02131764/document
Autor:
Delphine Carbonnelle, Michel Krempf, Nathalie Labarrière, François Lang, Maud Charpentier, Laetitia Florenceau, Agnès Fortun, Mikaël Croyal, Catherine Rabu
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2016, 7, ⟨10.18632/oncotarget.10923⟩
Oncotarget, Impact journals, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget 37 (7), 59704-59713. (2016)
Oncotarget, Impact journals, 2016, 7, ⟨10.18632/oncotarget.10923⟩
Oncotarget, Impact journals, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget, 2016, 7 (37), pp.59704-59713. ⟨10.18632/oncotarget.10923⟩
Oncotarget 37 (7), 59704-59713. (2016)
// Maud Charpentier 1 , Mikael Croyal 2, 3 , Delphine Carbonnelle 1 , Agnes Fortun 1 , Laetitia Florenceau 1, 4 , Catherine Rabu 1 , Michel Krempf 2, 3, 4 , Nathalie Labarriere 1, 4 , Francois Lang 1 1 CRCNA, INSERM, CNRS, Universite d’Angers, Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ab9674eccd8ff434f2cde6fbace64f
https://www.hal.inserm.fr/inserm-01409602
https://www.hal.inserm.fr/inserm-01409602
Autor:
Laetitia Florenceau, Nathalie Labarrière, Benjamin Chalopin, Delphine Fradin, Agnès Moreau-Aubry
Publikováno v:
Melanoma Research
Melanoma Research, 2015, ⟨10.1097/CMR.0000000000000167⟩
Melanoma Research, Lippincott, Williams & Wilkins, 2015, ⟨10.1097/CMR.0000000000000167⟩
Melanoma Research, 2015, ⟨10.1097/CMR.0000000000000167⟩
Melanoma Research, Lippincott, Williams & Wilkins, 2015, ⟨10.1097/CMR.0000000000000167⟩
International audience; We recently characterized two melanoma antigens MELOE-1 and MELOE-2 derived from a polycistronic RNA overexpressed in the melanocytic lineage. This transcription profile was because of hypomethylation of the meloe proximal pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f79a6b312d8de5f614e8d4efd3d2d3
https://www.hal.inserm.fr/inserm-01280880/document
https://www.hal.inserm.fr/inserm-01280880/document
Autor:
Sylvain Simon, François Lang, Laetitia Florenceau, Brigitte Dréno, Nathalie Labarrière, Virginie Vignard, Amir Khammari
Publikováno v:
OncoImmunology
OncoImmunology, Taylor & Francis, 2015, ⟨10.1080/2162402X.2015.1104448⟩
OncoImmunology, 2015, ⟨10.1080/2162402X.2015.1104448⟩
Oncoimmunology
OncoImmunology, Taylor & Francis, 2015, ⟨10.1080/2162402X.2015.1104448⟩
OncoImmunology, 2015, ⟨10.1080/2162402X.2015.1104448⟩
Oncoimmunology
Despite its negative regulatory role on tumor-specific T cells, Programmed cell death 1 (PD-1) is also a marker of activated tumor-infiltrating T cells. In cancer, PD-1 blockade partially reverses T cell dysfunction allowing the amplification of tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1bad092142b919334d7ab1199bd636
https://www.hal.inserm.fr/inserm-01280886/document
https://www.hal.inserm.fr/inserm-01280886/document
Autor:
Mathilde Allard, Laetitia Florenceau, Karine Bernardeau, Klara Echasserieau, Nadine Gervois, Romain Oger, François Lang, Nathalie Labarrière, Houssem Benlalam
Publikováno v:
Journal of Immunology
Journal of Immunology, 2014, 192 (11), pp.5090-5097. ⟨10.4049/jimmunol.1303226⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 192 (11), pp.5090-5097. ⟨10.4049/jimmunol.1303226⟩
Journal of Immunology, 2014, 192 (11), pp.5090-5097. ⟨10.4049/jimmunol.1303226⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2014, 192 (11), pp.5090-5097. ⟨10.4049/jimmunol.1303226⟩
Accumulating evidence that serum levels of soluble class I HLA molecules (sHLA-I) can, under various pathological conditions, correlate with disease stage and/or patient survival, has stimulated interest in defining whether sHLA-I can exert immunolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::babe8ffa2f03b6899be4a4454720c013
https://www.hal.inserm.fr/inserm-02481105/document
https://www.hal.inserm.fr/inserm-02481105/document
Autor:
Wolfgang Mikulits, Laetitia Florenceau, Agnès Moreau-Aubry, Nathalie Labarrière, Delphine Carbonnelle, Maud Charpentier, François Lang, Delphine Sehedic, Virginie Vignard
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2013, 8 (9), pp.e75233. ⟨10.1371/journal.pone.0075233⟩
PLoS ONE, Vol 8, Iss 9, p e75233 (2013)
PLoS ONE, 2013, 8 (9), pp.e75233. ⟨10.1371/journal.pone.0075233⟩
PLoS ONE, Public Library of Science, 2013, 8 (9), pp.e75233. ⟨10.1371/journal.pone.0075233⟩
PLoS ONE, Vol 8, Iss 9, p e75233 (2013)
PLoS ONE, 2013, 8 (9), pp.e75233. ⟨10.1371/journal.pone.0075233⟩
International audience; Our previous studies on melanoma antigens identified two new polypeptides, named MELOE-1 and MELOE-2, that are involved in immunosurveillance. Intriguingly, these antigens are coded by distinct open reading frames (ORF) of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0cf9d504021358654030934bd9e6bc
https://www.hal.inserm.fr/inserm-01726993
https://www.hal.inserm.fr/inserm-01726993